Replikins explains how an analysis of gene structures in the dengue virus led to the development of a vaccine candidate

How a Genetic Analysis of Dengue Led to the Vaccine Candidate

Replikins explains how an analysis of gene structures in the dengue virus led to the development of a vaccine candidate Replikins Ltd, the company that first identified a group of peptides called Replikins, has announced that one of its studies on the genetic structure of the dengue virus has been instrumental in the development of their synthetic dengue vaccine candidate. …

Ebola Virus Gene Replikin Count Increased Sixteen-fold in 2013 in Advance of Current Outbreaks

July 30th, 2014 Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and 2002 was 1.1; the mean Replikin Count increased twofold in 2010, threefold in 2012, and sixteen-fold in 2013, thus predicting …

Mers-CoV ‘On Course’ According to the Published Genomic Replikin Count Predictions of 2012 and 2013

Comparison with the Replikins Counts and Course of the SARS Outbreak of 2003 and the H1N1 Pandemic of 2009 Completed in 4 days, First Batch of 20,000 doses of Freeze-Dried Solid Phase Synthetic Anti-Mers-CoV Vaccine Is Ready for Testing Today April 30, 2014 Bioradar UK Ltd. and Replikins Ltd. announced today that the clinical course of the current Mers-CoV outbreak …